Industry: Health care Region: Germany Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A high-tech start-up company in Germany is committed to the production and distribution of new rapid tests. These tests are used to detect analytes such as pesticides, toxins, cell inhibitors and antibiotics. Rapid testing can be used for human and veterinary, as well as food industry and environmental analysis. In order to facilitate field application, the company's products are stored at room temperature of 2 C to 30 C. Within 3 to 15 minutes, rapid detection can provide reliable results without laboratory participation.
Company product introduction:
The company has developed the next generation POCT, which is a patented product for accurate and reliable quantitative analysis, and is called "qPOCT". The analyte can be drugs (such as cell inhibitors and antibiotics) in human and animal blood, and it can also be contaminated by antibiotics/toxins in food.
The product can be used for targeted drug monitoring. In Europe, the detection cost of antibiotics and toxins for medical and food safety is about 25-100 euros, and the detection method can only be carried out in modern laboratories. Compared with the standard method, the product can reduce the cost and time of detection by more than 100 times, and the technical operation is simple without any approved laboratory.
Product application field:
Detection of analytes such as pesticides, toxins, cell inhibitors and antibiotics
Human and veterinary applications
Application of food industry and environmental analysis
Cooperation mode:
Investors and distributors seeking POCT- kits from China, whose POCT products have been put on the market and need more investment to produce and certify new products.